...
首页> 外文期刊>Journal of Health Services Research & Policy >The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold
【24h】

The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold

机译:最大的好处还是更大的好处:成本效益阈值的谬误

获取原文
获取原文并翻译 | 示例
           

摘要

It has been suggested that scepticism among decision-makers about using cost-e!ectiveness analysisn(CEA) is caused in part by the low level of the cost-e!ectiveness ‘thresholds’ in the economic evaluation literature.nThis has led Ubel and colleagues to call for higher threshold values of US$200,000 or more per quality-nadjusted life-year.We show that these arguments fail to identify the objective of CEA and hence do notnconsider whether or how the threshold relates to this objective.We show that incremental cost-e!ectivenessnratios (ICERs) cannot be used to identify an e⁄cient use of resources -- the ‘biggest bang for the bucks’ --nallocated to health care. On the contrary, the practical consequence of using the ICER approach is shown tonbe an increase in health care expenditures, or ‘bigger bucks for making a bang’, without any evidence of thenbang being bigger (i.e. that this leads to an increase in bene¢ts to the population).We present an alternativenapproach that provides an unambiguous method of determining whether a new intervention leads to an increasenin health gains fromwhatever resources are to bemade available to health care decision-makers.
机译:有人认为,决策者对使用成本效益分析n(CEA)的怀疑部分是由于经济评估文献中成本效益“阈值”的水平较低而引起的。同事呼吁将每个质量调整生命年的门槛值提高到200,000美元或更高。我们表明,这些论点未能确定CEA的目标,因此未考虑门槛值是否与该目标相关联,我们并未考虑此门槛成本效益比(ICER)不能用于识别对资源的有效利用-分配给医疗保健的“最大的负担”。相反,表明使用ICER方法的实际结果表明医疗保健支出增加了,或者说“大赚钱”,而没有任何证据表明“ bangbang更大”(即,这导致受益增加)。我们为您提供了一种替代方法,该方法提供了一种明确的方法来确定新的干预措施是否会从医疗决策者可利用的任何资源中增加健康收益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号